Senior Research Investigator @ Array Biopharma (October 2008 - November 2009)
Research Investigator @ Array Biopharma (October 2005 - October 2008)
Research Fellow @ (April 2004 - October 2005)
Senior Research Chemist @ (February 2001 - March 2004)
Research Assistant Professor @ (January 1999 - February 2001)
Dylan Hartley Education
University of Kansas Medical Center
Post-Doctoral Studies (Toxicology Fellow)
1996-1999
University of Colorado Anschutz
Ph.D. (Toxicology and Pharmaceutical Sciences)
1990-1996
Dylan Hartley Skills
ADME
Biochemistry
Biomarkers
Biotechnology
Cell Biology
Chemistry
Clinical Data
Clinical Development
Clinical Strategy
Clinical Trials
Compensation & Benefits
DMPK
Drug Development
Drug Discovery
Drug Metabolism
In Vitro
In Vivo
Lead Change
Learning
Life Sciences
Neuroscience
Oncology
Pharmaceutical Industry
Pharmacokinetics
Pharmacology
Pre-clinical Studies
Precision Medicine
Research and Development (R&D)
Resource Management
Therapeutic Areas
Toxicology
Value Creation
Microsoft Office
Research
Leadership
Dylan Hartley Summary
Dylan Hartley, based in Boulder, CO, US, is currently a Chief Scientific Officer at OnKure Therapeutics. Dylan Hartley brings experience from previous roles at Pfizer and Array BioPharma Inc.. Dylan Hartley holds a 1996 - 1999 Post-Doctoral Studies in Toxicology Fellow @ University of Kansas Medical Center. With a robust skill set that includes ADME, Biochemistry, Biomarkers, Biotechnology, Cell Biology and more. Dylan Hartley has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Dylan Hartley?
Find contact details for 700 million professionals.